Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Carnitine metabolism during exercise

E P Brass1, W R Hiatt

  • 1Department of Medicine, Case Western Reserve University, Cleveland, Ohio 44106-4981.

Life Sciences
|January 1, 1994
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Regulatory Pathways for New Antimicrobial Agents: Trade-offs to Keep the Perfect From Being the Enemy of the Good.

Clinical pharmacology and therapeutics·2016
Same author

Structured Frameworks to Increase the Transparency of the Assessment of Benefits and Risks of Medicines: Current Status and Possible Future Directions.

Clinical pharmacology and therapeutics·2015
Same author

Multicenter randomized controlled trial on Duration of Therapy for Thrombosis in Children and Young Adults (the Kids-DOTT trial): pilot/feasibility phase findings.

Journal of thrombosis and haemostasis : JTH·2015
Same author

Toxicity of a novel therapeutic agent targeting mitochondrial complex I.

Clinical pharmacology and therapeutics·2015
Same author

Mitochondria as targets of drug toxicity: Lessons from the R118 phase I experience.

Clinical pharmacology and therapeutics·2015
Same author

Response to ‘Statement from the European Society of Vascular Surgery and the World Federation of Vascular Surgery Societies’ Inter-Society Consensus Document (TASC) III and International Standards for Vascular Care (ISVaC).

European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery·2014
Same journal

Corrigendum to "Adipose stem cells-derived microvesicles and chicken egg-derived exosomes attenuate cardiac ischemia/reperfusion injury through AKT/ERK/Nrf2/HO-1 axis to inhibit apoptosis and inflammation and restore autophagy" [Life Sci. 395 (2026) 124364].

Life sciences·2026
Same journal

MAGED1 stabilizes NEUROD1 to promote Per3 expression in the pineal gland.

Life sciences·2026
Same journal

TNF-centered network pharmacology and molecular modeling of selected Andrographis paniculata compounds in hypertension.

Life sciences·2026
Same journal

Retraction notice to "Beneficial effect of Calculus Bovis Sativus on 17α-ethynylestradiol-induced cholestasis in the rat" [Life Sci. 113 (2014) 22-30].

Life sciences·2026
Same journal

Soluble PD-1 drives renal fibrosis in CKD by disrupting immune homeostasis: Therapeutic mitigation via a targeted sPD-1 sequestration strategy.

Life sciences·2026
Same journal

METTL1 promotes hepatic steatosis by mediating m<sup>7</sup>G modification of ALOX15B mRNA.

Life sciences·2026
See all related articles

Adequate carnitine stores are vital for muscle energy production during exercise. Carnitine supplementation may improve exercise tolerance in patients with peripheral arterial disease and chronic renal failure.

Area of Science:

  • Exercise Physiology
  • Cellular Metabolism
  • Biochemistry

Background:

  • Carnitine is essential for cellular metabolism and ATP generation in skeletal muscle during exercise.
  • Muscle carnitine pools are largely separate from extracellular sources during exercise.
  • Exercise intensity influences carnitine metabolism in skeletal muscle.

Purpose of the Study:

  • To investigate the role of carnitine in skeletal muscle metabolism during exercise.
  • To examine carnitine and acetylcarnitine changes in relation to exercise intensity and disease states.
  • To evaluate the efficacy of carnitine supplementation in improving exercise tolerance in specific patient populations.

Main Methods:

  • Analysis of muscle carnitine and acetylcarnitine content in relation to exercise workloads.

Related Experiment Videos

  • Comparison of carnitine metabolism in healthy subjects versus patients with peripheral arterial disease and chronic renal failure.
  • Assessment of exercise tolerance following carnitine supplementation.

    • Main Results:

    • In healthy individuals, muscle carnitine shifts to acetylcarnitine above the lactate threshold, correlating with acetyl-CoA and lactate levels.
    • Patients with peripheral arterial disease show acylcarnitine accumulation at all exercise intensities.
    • Patients with chronic renal failure on hemodialysis exhibit reduced muscle carnitine and poor exercise capacity.
    • Carnitine supplementation improved exercise tolerance in both patient groups.

    Conclusions:

    • Muscle carnitine metabolism is altered by exercise intensity and disease.
    • Carnitine deficiency impacts exercise performance in peripheral arterial disease and chronic renal failure.
    • Carnitine supplementation shows promise for enhancing exercise tolerance in these patient populations.
    • Further research is needed to elucidate the mechanisms and optimize carnitine therapy for exercise performance.